Maxitrol is an anti-inflammatory and antibacterial drug used in ophthalmology.
Release form and composition
Maxitrol dosage form - eye drops (5 ml in vials, equipped with a Drop Tainer dosing device, in a carton box, 1 vial).
1 ml drops contain the following active ingredients:
- Dexamethasone - 1 mg;
- Polymyxin B sulfate - 6000 U;
- Neomycin sulfate - 3500 U.
Excipients: polysorbate 20, hydroxypropyl methylcellulose, distilled water, neutral additives, and also preservative benzalkonium chloride.
Indications for use
Maxitrol is intended for the treatment of infectious diseases of the eye and its appendages, such as:
Also, the drug is used to prevent postoperative inflammation of the anterior part of the eye.
- Tuberculous diseases of the eye;
- Mycobacterial infection of the eye;
- Viral diseases of the eye (including chickenpox, as well as keratitis caused by the herpes simplex virus);
- Fungal diseases of the eye;
- Purulent corneal ulcer;
- Purulent infection of the mucous membrane of the eye and eyelids caused by microorganisms resistant to neomycin;
- Condition after removal of a foreign body of the cornea;
- Acute shingles;
- Individual hypersensitivity to any component of this drug.
Relative (special caution required):
The experience of using Maxitrol during pregnancy is not enough to assess its safety, therefore, during this period of life, the drug can be prescribed only if the expected benefit exceeds the possible risks.
If necessary, the use of the drug during lactation, breastfeeding for the period of treatment is recommended to interrupt.
Safety and efficacy of Maxitrol for children have not been established.
Dosing and Administration
The drug should be dripped into the conjunctival sac of the affected eye.
With a mild infectious process is usually prescribed 1-2 drops every 4-6 hours. With a severe course of the disease, the drug must be instilled at the beginning every hour, then, as the inflammation decreases, the time between instillations is increased.
- Local allergic reactions: itching and swelling of the eyelids, conjunctival redness;
- Effects caused by dexamethasone: slowing down the process of wound healing, posterior subcapsular cataract, increased intraocular pressure with possible subsequent damage to the visual field and optic nerve, as well as the development of glaucoma; in diseases that cause thinning of the sclera or cornea - perforation of the sclera / cornea.
With long-term use of Maxitrol, secondary infections may occur, namely fungal lesions of the cornea, the development of which may be indicated by the appearance of non-healing ulcers on the cornea after prolonged treatment.
Before each instillation vial should be shaken, after each use - close tightly.
In the case of long-term treatment (more than 10 days), it is necessary to monitor intraocular pressure, since there is a risk of developing glaucoma, damage to the optic nerve and visual fields.
The interaction of Maxitrol with other drugs is not known.
If necessary, the simultaneous use of other local ophthalmic drugs should withstand at least 10-minute intervals between instillations.
Terms and conditions of storage
Store in an upright position at a temperature of 8 to 30 ºС out of the reach of children.
Expiration date - 2 years, after opening the bottle - 4 weeks.